Indications:
Hypertension:
For the treatment of essential hypertension in adults.
Reduction of cardiovascular risk
This product is applicable to patients aged 55 years and older at high risk of major cardiovascular events who are unable to tolerate angiotensin-converting enzyme (ACE) inhibitor therapy, to reduce the risk of myocardial infarction, stroke, or cardiovascular death. High risk of cardiovascular events includes a history of coronary artery disease, peripheral arterial disease, stroke, transient ischemic attack, or high-risk type 2 diabetes mellitus with evidence of end-organ damage. Telmisartan may also be used concomitantly with other necessary treatments (e.g., antihypertensive drugs, antiplatelet agents, or lipid-lowering drugs).
Concomitant use of telmisartan with ACE inhibitors is not recommended.

Strength:40mg、80mg

National Drug Approval Number:H20040805、H20050934